Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Epstein-Barr virus associated lymphoproliferative disorder
ADR ID BADD_A06512
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.02      Lymphoproliferative disorders NEC (excl leukaemias and lymphomas)
01.13.02.002      Epstein-Barr virus associated lymphoproliferative disorder
11      Infections and infestations
11.05      Viral infectious disorders
11.05.10      Epstein-Barr viral infections
11.05.10.001      Epstein-Barr virus associated lymphoproliferative disorder
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.02      Lymphoproliferative disorders NEC (excl leukaemias and lymphomas)
16.21.02.002      Epstein-Barr virus associated lymphoproliferative disorder
Description Not Available
MedDRA Code 10068349
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Epstein-Barr virus associated lymphoproliferative disorder
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine0.000940%
BADD_D00223Belatacept--
BADD_D00551Cyclosporine0.000332%
BADD_D00589Dasatinib0.000224%
BADD_D01136Imatinib0.000392%
BADD_D01418Methotrexate0.001194%
BADD_D01814Pralatrexate0.000112%
BADD_D01831Prednisolone0.000052%
BADD_D01834Prednisone0.000013%
BADD_D02105Tacrolimus0.001188%
The 1th Page    1    Total 1 Pages